Crinetics Pharmaceuticals, Inc. (CRNX) › Net IncomeCrinetics Pharmaceuticals, Inc. (CRNX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$6.02M2017: -$9.16M2018: -$27.11M2019: -$50.42M2020: -$73.81M2021: -$107.64M2022: -$163.92M2023: -$214.53M2024: -$298.41M2025: -$465.32M-$465.32M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$465.32M-55.9%2024-$298.41M-39.1%2023-$214.53M-30.9%2022-$163.92M-52.3%2021-$107.64M-45.8%2020-$73.81M-46.4%2019-$50.42M-86.0%2018-$27.11M-196.1%2017-$9.16M-52.1%2016-$6.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share